Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Coloplast ASCLPBY -1.47%77 5-Year Dividend Growth Rate is 5.30% as of Mar. 2026. GuruFocus rates CLPBY with a GF Score™ of 77/100 and a GF Value™ of $13.05 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 163 Medical Devices & Instruments companies, Coloplast AS ranks worse than 65.03% on this metric.
During the past 12 months, Coloplast AS's average Dividends Per Share Growth Rate was 4.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 6.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Coloplast AS was 79.20% per year. The lowest was 3.60% per year. And the median was 17.00% per year.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Coloplast AS is 0.98, which seems too high.
Good Sign:
Coloplast AS stock Dividend Yield % is close to 10-year high.
For more information regarding to dividend, please check our Dividend Page.
During the past 13 years, the highest Dividend Payout Ratio of Coloplast AS was 0.98. The lowest was 0.71. And the median was 0.84.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Coloplast AS is 0.98, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Coloplast AS Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.077742
2026-05-22
2026-05-22
2026-06-01
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.282118
2025-12-08
2025-12-08
2025-12-19
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Coloplast AS's Dividend Yield (%) for Today is calculated as
Current Share Price is $6.70.
Coloplast AS's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.35986.
During the past 13 years, the highest Dividend Yield of Coloplast AS was 6.07%. The lowest was 1.51%. And the median was 2.38%.
Good Sign:
Coloplast AS stock Dividend Yield % is close to 10-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS 5-Year Dividend Growth Rate Related Terms
CLPBY vs ISRG, BDX, MDLN: 5-Year Dividend Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS 5-Year Dividend Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's 5-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Coloplast AS's 5-Year Dividend Growth Rate falls into.
Coloplast AS 5-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 5-Year Dividend Growth Rate of 5.30% mean?
Coloplast AS (CLPBY) has a 5-Year Dividend Growth Rate of 5.30% as of Mar. 2026. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Coloplast AS and its competitors. According to the industry distribution chart, Coloplast AS ranks #106 out of 163 companies in the Medical Devices & Instruments industry, placing it in the top 65%.
Is Coloplast AS's 5-Year Dividend Growth Rate too high?
Coloplast AS's current 5-Year Dividend Growth Rate is 5.30%. The Medical Devices & Instruments industry median 5-Year Dividend Growth Rate is 9.40. Coloplast AS's value of 5.30% is 43.6% below this industry median. Based on the distribution chart, Coloplast AS ranks #106 out of 163 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Coloplast AS has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's 5-Year Dividend Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #106 out of 163 companies for 5-Year Dividend Growth Rate. This places Coloplast AS in the lower half of its industry. The industry median 5-Year Dividend Growth Rate is 9.40. Coloplast AS's value of 5.30% is 43.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Dividend Growth Rate for a Medical Devices & Instruments company?
The median 5-Year Dividend Growth Rate among Medical Devices & Instruments companies is 9.40, based on 163 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current 5-Year Dividend Growth Rate of 5.30% is 43.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Dividend Growth Rate mean?
A high 5-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Dividend Growth Rate is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current 5-Year Dividend Growth Rate is 5.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.05, compared to a current price of $6.70 — trading 48.7% below its estimated fair value. The current 5-Year Dividend Growth Rate is 5.30% and 43.6% below the Medical Devices & Instruments industry median of 9.40. Coloplast AS's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Dividend Growth Rate calculated?
5-Year Dividend Growth Rate is calculated from a company's financial statements. For Coloplast AS (CLPBY), the current 5-Year Dividend Growth Rate is 5.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBY) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $6.70 is trading 48.7% below its estimated GF Value™ of $13.05.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBY:
5-Year Dividend Growth Rate: 5.30%
GF Value™: $13.05 vs. price of $6.70 (48.7% below fair value)
Industry Position: 43.6% below the Medical Devices & Instruments median (#106 of 163)
No single metric tells the full story. See the CLPBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
77GF Score
Get the complete analysis for CLPBY
5-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBY has been successfully added to your 
